Menu

1 / 5

Could one daily pill narrow the diabetes treatment gap in the Global South?

#aljazeeracom#news#aljazeera#diabetes#percent
Reading 0:00
15s threshold

Medication that has been a lifeline for patients with uncontrollable diabetes is now slowly shifting from injections to pills, a move that could fundamentally alter treatment for the disease – and who can access it.

This shift could also affect the treatment of obesity, a long misunderstood condition once associated with overeating and laziness, rather than the metabolic disorder it is now recognised as.

Recommended Stories

list of 4 items list 1 of 4 Can GLP-1 drugs like Ozempic cause vision loss? What we know about the risk

list 2 of 4 Sweet scoop: Ice-cream study points to potential sugar substitute

list 3 of 4 Food or medicine? The impossible choices facing Sudan’s chronically ill

list 4 of 4 With every rainfall, Gaza risks losing access to power and healthcare

end of list

GLP-1 (glucagon-like peptide-1) receptor agonists therapy isn’t new.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.